How important is understanding the tumour microenvironment in treating CLL?
Isavuconazole treatment for fungal disease in leukemia patients
A new prognostic tool for CLL: CLL-IPI
2 years on: Deborah discusses her venetoclax trial and becoming MRD negative
Deborah Henderson et al.
Ibrutinib vs chlorambucil in CLL patients not suitable for chemotherapy